KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5255.03M
Enterprise Value 3171.65M
Trailing P/E N/A
Forward P/E 1-10.32
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)85.51
Price/Book (mrq)4.34
Enterprise Value/Revenue 357.55
Enterprise Value/EBITDA 6-6.89

Trading Information

Stock Price History

Beta (3Y Monthly) 3.98
52-Week Change 364.23%
S&P500 52-Week Change 37.14%
52 Week High 34.3500
52 Week Low 30.8700
50-Day Moving Average 32.7923
200-Day Moving Average 32.7520

Share Statistics

Avg Vol (3 month) 3836.15k
Avg Vol (10 day) 3536.99k
Shares Outstanding 5112.35M
Float 74.49M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jun 14, 2019) 41.13M
Short Ratio (Jun 14, 2019) 41.82
Short % of Float (Jun 14, 2019) 4N/A
Short % of Shares Outstanding (Jun 14, 2019) 41.02%
Shares Short (prior month May 15, 2019) 43.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-849.35%

Management Effectiveness

Return on Assets (ttm)-48.18%
Return on Equity (ttm)-105.17%

Income Statement

Revenue (ttm)2.98M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)297.36k
EBITDA -24.91M
Net Income Avi to Common (ttm)-25.8M
Diluted EPS (ttm)-0.4360
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)38.39M
Total Cash Per Share (mrq)0.42
Total Debt (mrq)2.55M
Total Debt/Equity (mrq)5.32
Current Ratio (mrq)4.74
Book Value Per Share (mrq)0.52

Cash Flow Statement

Operating Cash Flow (ttm)-19M
Levered Free Cash Flow (ttm)-14.73M